| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 242 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7 |
| Gross Profit/Loss - EUR | -166 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Net Profit/Loss - EUR | -169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - D & C Polimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.512 | 9.415 | 9.255 | 9.085 | 8.909 | 8.741 | 8.547 | 8.573 | 8.547 | 8.499 |
| Current Assets | 136 | 134 | 132 | 130 | 127 | 125 | 122 | 122 | 122 | 121 |
| Inventories | 15 | 14 | 14 | 14 | 14 | 13 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 14 | 0 | 0 |
| Cash | 121 | 119 | 117 | 115 | 113 | 111 | 108 | 109 | 122 | 121 |
| Shareholders Funds | -9.199 | -9.105 | -8.951 | -8.787 | -8.616 | -8.453 | -8.266 | -8.291 | -8.266 | -8.213 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.846 | 18.654 | 18.338 | 18.002 | 17.653 | 17.318 | 16.934 | 16.987 | 16.935 | 16.833 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - D & C Polimed S.r.l.